» Articles » PMID: 12086400

Suppressive Effect of Natural Sesquiterpenoids on Inducible Cyclooxygenase (COX-2) and Nitric Oxide Synthase (iNOS) Activity in Mouse Macrophage Cells

Overview
Publisher Begell House
Date 2002 Jun 28
PMID 12086400
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Prostaglandins and nitric oxide produced by inducible cyclooygenase (COX-2) and nitric oxide synthase (iNOS), respectively, have been implicated as important mediators in the processes of inflammation and carcinogenesis. These potential COX-2 and iNOS inhibitors have been considered as antiinflammatory and cancer chemopreventive agents. In this study, we investigated the effect of natural sesquiterpenoids isolated from plants of the Zingiberaceae family on the activities of COX-2 and iNOS in cultured lipopolysaccharide (LPS)-activated mouse macrophage cell RAW 264.7 to discover new lead compounds as COX-2 or iNOS inhibitors. Xanthorrhizol, a sesquiterpenoid, isolated from the rhizome of Curcuma xanthorrhiza Roxb. (Zingiberaceae), exhibited a potent inhibition of COX-2 (IC50 = 0.2 microg/mL) and iNOS activity (IC50 = 1.0 microg/mL) in the assay system of prostaglandin E2 (PGE2) accumulation and nitric oxide production, respectively. Western blot analyses revealed that the inhibitory potential of xanthorrhizol on the COX-2 activity coincided well with the suppression of COX-2 protein expression in LPS-induced macrophages. In addition, sesquiterpenoids beta-turmerone and ar-turmerone isolated from the rhizome of Curcuma zedoaria Roscoe (Zingiberaceae) also showed a potent inhibitory activity of COX-2 (beta-turmerone, IC50 = 1.6 microg/mL; ar-turmerone, IC50 = 5.2 microg/mL) and iNOS (beta-turmerone, IC50 = 4.6 microg/mL; ar-turmerone, IC50 = 3.2 microg/mL). These results suggest that natural sesquiterpenoids from C. xanthorrhiza and C. zedoaria might be lead candidates for further developing COX-2 or iNOS inhibitors possessing cancer chemopreventive or anti-inflammatory properties.

Citing Articles

Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial.

Seydi F, Salehi M, Hashem-Dabaghian F, Emadi F, Gholami-Fesharaki M, Iranzadasl M Avicenna J Phytomed. 2023; 13(4):388-399.

PMID: 37663385 PMC: 10474915. DOI: 10.22038/AJP.2023.21829.


Optimized Solvents for the Maceration of Phenolic Antioxidants from Rhizome using a Simplex Centroid Design.

Nurcholis W, Marliani N, Asyhar R, Minarni M J Pharm Bioallied Sci. 2023; 15(1):35-41.

PMID: 37313536 PMC: 10259739. DOI: 10.4103/jpbs.jpbs_185_23.


Anti-Inflammatory and Antioxidant Chinese Herbal Medicines: Links between Traditional Characters and the Skin Lipoperoxidation "Western" Model.

Prieto J, Schinella G Antioxidants (Basel). 2022; 11(4).

PMID: 35453296 PMC: 9030610. DOI: 10.3390/antiox11040611.


In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2.

Kim M, Cho H, Ahn D, Jung H, Seo H, Kim J Biomedicines. 2021; 9(11).

PMID: 34829954 PMC: 8615586. DOI: 10.3390/biomedicines9111725.


In vitro and in vivo evaluation of a standardized Curcuma longa Linn formulation in cervical cancer.

Paradkar P, Juvekar A, Barkume M, Amonkar A, Joshi J, Soman G J Ayurveda Integr Med. 2021; 12(4):616-622.

PMID: 34531090 PMC: 8642669. DOI: 10.1016/j.jaim.2021.06.002.